ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

AIM AIM ImmunoTech Inc

0.4085
-0.0034 (-0.83%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
AIM ImmunoTech Inc AIM AMEX Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0034 -0.83% 0.4085 09:44:21
Open Price Low Price High Price Close Price Previous Close
0.42 0.3926 0.42 0.4085 0.4119
more quote information »

Recent News

Date Time Source Heading
29/4/202422:55GLOBEAIM ImmunoTech Announces First Dose Level is Generally..
25/4/202422:45GLOBEAIM ImmunoTech Announces Release of the Next CEO Corner..
18/4/202422:45GLOBEAIM ImmunoTech Announces Release of the Next CEO Corner..
15/4/202422:55GLOBEAIM ImmunoTech Announces Charles Lapp, MD, as a Consulting..
12/4/202401:00GLOBEAIM ImmunoTech Announces Release of the Next CEO Corner..
10/4/202422:21GLOBEAIM ImmunoTech Announces Positive Top-Line, Protocol-Planned..
02/4/202422:30GLOBEAIM ImmunoTech Reports Fourth Quarter and Full Year 2023..
28/3/202423:05GLOBEAIM ImmunoTech to Present at the MedInvest Biotech & Pharma..
27/3/202400:05GLOBEAIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023..
26/3/202400:05GLOBEAIM ImmunoTech Announces Publication of Positive Findings..
22/3/202423:55GLOBEAIM ImmunoTech Announces Release of the Next CEO Corner..
21/3/202400:25GLOBEAIM ImmunoTech Announces Release of the Next CEO Corner..
15/3/202423:45GLOBEAIM ImmunoTech to Participate in the Virtual Investor Lunch..
08/3/202400:45GLOBEAIM ImmunoTech Announces Launch of CEO Corner Platform
01/3/202400:45GLOBEAIM ImmunoTech Outlines Recent Progress Across Clinical..
22/2/202402:37EDGAR2Form D/A - Notice of Exempt Offering of Securities: [Amend]
21/2/202408:31EDGAR2Form 8-K - Current report
15/2/202400:55GLOBEAIM ImmunoTech Announces First Subject Dosed in the..
10/2/202407:47EDGAR2Form 8-K - Current report
09/2/202400:50GLOBEAIM ImmunoTech Reports Positive Topline Results from Phase 2..
26/1/202409:00EDGAR2Form 8-K - Current report
25/1/202401:10GLOBEAIM ImmunoTech Receives Erasmus Medical Center Ethics Board..
23/1/202400:55GLOBEAIM ImmunoTech Announces that the First Subject is Enrolled..
11/1/202405:42EDGAR2Form 8-K - Current report
11/1/202400:45EDGAR2Form 8-K - Current report
11/1/202400:45GLOBEAIM ImmunoTech Announces Open Enrollment for Phase 1b/2..
06/1/202405:32BWAIM Shareholders Elect All Four Company Director Nominees at..
04/1/202408:24EDGAR2Form SC 13D/A - General statement of acquisition of..
04/1/202408:24EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
04/1/202408:05PRNUSKellner Seeking Expedited Appeal of Delaware Court Finding..
30/12/202300:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
30/12/202300:00BWDelaware Court Rules in Favor of AIM ImmunoTech and Upholds..
29/11/202308:54EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/11/202308:30BWAIM ImmunoTech Provides Update Regarding Annual Meeting
28/11/202304:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202301:05GLOBEAIM ImmunoTech Bolsters Intellectual Property Estate for..
22/11/202304:00GLOBEAIM ImmunoTech Completes Treatment of Last Subject in Phase..
21/11/202309:29EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
21/11/202301:05EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
20/11/202323:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
17/11/202301:21EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
15/11/202323:30EDGAR2Form 8-K - Current report
15/11/202323:30GLOBEAIM ImmunoTech Reports Third Quarter 2023 Financial Results..
15/11/202302:00GLOBEAIM ImmunoTech Announces Publication of Data from Roswell..
10/11/202300:05GLOBEAIM ImmunoTech to Discuss Third Quarter 2023 Financial..
09/11/202308:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09/11/202300:45EDGAR2Form 8-K - Current report
09/11/202300:45GLOBEAIM ImmunoTech Announces Encouraging Translational Data from..
07/11/202322:03EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/11/202301:25BWAIM ImmunoTech Files Definitive Proxy Statement and Sends..

Your Recent History

Delayed Upgrade Clock